跳至主要内容
临床试验/JPRN-jRCTs031180339
JPRN-jRCTs031180339招募中2 期

Exploratory study on the anti-proliferative effects of metformin on endometrial cancer

Habu Yuji0 个研究点目标入组 15 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 60age old(—)
性别
Female

入选标准

  • •1.Histologically confirmed grade 1-2 endometrioid adenocarcinoma
  • •2.BMI over 25 and positive for insulin resistance
  • •3.Over 20 years and under 60 years of age
  • •4.Eastern Cooperative Oncology Group Performance status 0
  • •5.Patient who are ready to provide written informed consent

排除标准

  • •1. Prior medical history of chemical sensitivity to metformin
  • •2. Serum creatinine over1.0 mg/dl
  • •3.History of lactic acidosis
  • •4.Patients undergoing dialysis
  • •5.Shock, cardiac arrest, cardiac infarction, thrombosis of the lung, or severe cardiovascular and/or lung damage
  • •6.Ingestion of excessive amounts of alcohol
  • •7.Elevated levels of AST(GOT), ALT(GPT) (over2 times upper limit of normal)
  • •8.History of thrombosis
  • •9.Mental illness that may require the administration of antipsychotics
  • •10.Diabetes mellitus that requires medication
  • •11.HbA1c over 8.0
  • •12.Concomitant malignancies
  • •13.Determined to be ineligible by the physician in charge for any other reason

研究者

发起方
Habu Yuji

相似试验

Exploratory study on the anti-proliferative effects... | 临床试验